Lataa...
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Cladribine is a purine nucleoside analog initially developed in the 1970s as a treatment for various blood cancers. Due to the molecule’s ability to preferentially reduce T and B lymphocytes, it has been developed into an oral formulation for the treatment of multiple sclerosis (MS). The unique prop...
Tallennettuna:
| Julkaisussa: | Drugs |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7708385/ https://ncbi.nlm.nih.gov/pubmed/33247831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01422-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|